Literature DB >> 30348697

Geranylgeraniol-induced Myogenic Differentiation of C2C12 Cells.

Takuma Matsubara1, Mariko Urata1, Tsuyoshi Nakajima1, Mari Fukuzaki1, Ryo Masuda1, Yoshiyuki Yoshimoto1, William N Addison2, Chihiro Nakatomi1, Kazmasa Morikawa3, Min Zhang4, Katsura Saeki5, Yukiko Takahashi6, Atsuko Nakamichi6, Shoichiro Kokabu7.   

Abstract

BACKGROUND: Geranylgeraniol (GGOH) is a C20 isoprenoid found in fruits, vegetables, and grains, including rice. As a food substance, GGOH is categorized as 'Generally Recognized as Safe'. GGOH is an intermediate product in the mevalonate pathway and acts as a precursor to geranylgeranyl pyrophosphate.
MATERIALS AND METHODS: C2C12 mouse myoblasts derived from muscle satellite cells were used. Quantitative reverse-transcriptase polymerase chain reaction, western blotting analysis, and immunocytochemical analysis were performed to respectively assess mRNA expression, protein levels, and the number of myofibers.
RESULTS: GGOH reduced the expression levels of skeletal muscle atrophy-related ubiquitin ligases in myofibers derived from C2C12 cells. GGOH induced myogenic differentiation of C2C12 cells via geranylgeranylation. GGOH did not adversely affect the proliferation of C2C12 cells.
CONCLUSION: GGOH induces myoblast differentiation in C2C12 cells. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  C2C12 cells; Sarcopenia; geranylgeranylation; myogenesis; statin

Mesh:

Substances:

Year:  2018        PMID: 30348697      PMCID: PMC6365721          DOI: 10.21873/invivo.11395

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.

Authors:  Richard C Pasternak; Sidney C Smith; C Noel Bairey-Merz; Scott M Grundy; James I Cleeman; Claude Lenfant
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

3.  Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle.

Authors:  E R Barton-Davis; D I Shoturma; H L Sweeney
Journal:  Acta Physiol Scand       Date:  1999-12

Review 4.  Targeting Ras and Rho GTPases as opportunities for cancer therapeutics.

Authors:  Katharine Walker; Michael F Olson
Journal:  Curr Opin Genet Dev       Date:  2005-02       Impact factor: 5.578

Review 5.  Statin-associated myopathy.

Authors:  Paul D Thompson; Priscilla Clarkson; Richard H Karas
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

6.  Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.

Authors:  Joost Frenkel; Ger T Rijkers; Saskia H L Mandey; Sandra W M Buurman; Sander M Houten; Ronald J A Wanders; Hans R Waterham; Wietse Kuis
Journal:  Arthritis Rheum       Date:  2002-10

7.  The healthcare costs of sarcopenia in the United States.

Authors:  Ian Janssen; Donald S Shepard; Peter T Katzmarzyk; Ronenn Roubenoff
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

8.  "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II.

Authors:  J R Florini; K A Magri; D Z Ewton; P L James; K Grindstaff; P S Rotwein
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

9.  Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes.

Authors:  Tomoyuki Nishimoto; Ryuichi Tozawa; Yuichiro Amano; Takeo Wada; Yoshimi Imura; Yasuo Sugiyama
Journal:  Biochem Pharmacol       Date:  2003-12-01       Impact factor: 5.858

10.  Muscle satellite cells adopt divergent fates: a mechanism for self-renewal?

Authors:  Peter S Zammit; Jon P Golding; Yosuke Nagata; Valérie Hudon; Terence A Partridge; Jonathan R Beauchamp
Journal:  J Cell Biol       Date:  2004-07-26       Impact factor: 10.539

View more
  2 in total

1.  Oral Administration of Geranylgeraniol Rescues Denervation-induced Muscle Atrophy via Suppression of Atrogin-1.

Authors:  Aki Miyawaki; Thira Rojasawasthien; Suzuro Hitomi; Yoshinori Aoki; Mariko Urata; Asako Inoue; Takuma Matsubara; Kazumasa Morikawa; Manabu Habu; Kazuhiro Tominaga; Shoichiro Kokabu
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 2.  Disease-associated metabolic alterations that impact satellite cells and muscle regeneration: perspectives and therapeutic outlook.

Authors:  Josiane Joseph; Jason D Doles
Journal:  Nutr Metab (Lond)       Date:  2021-03-25       Impact factor: 4.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.